These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26613760)

  • 21. Cystatin C as a Predictor of In-Hospital Mortality After Exacerbation of COPD.
    Hu G; Wu Y; Zhou Y; Yu Y; Liang W; Ran P
    Respir Care; 2016 Jul; 61(7):950-7. PubMed ID: 27072013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
    Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
    Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
    Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker.
    Ruzsics I; Nagy L; Keki S; Sarosi V; Illes B; Illes Z; Horvath I; Bogar L; Molnar T
    COPD; 2016; 13(2):139-45. PubMed ID: 26514682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease.
    Kirdar S; Serter M; Ceylan E; Sener AG; Kavak T; Karadağ F
    Scand J Clin Lab Invest; 2009; 69(2):219-24. PubMed ID: 18946779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood
    Liu C; Zhu J; Zhao L; Li G; Sun J; Zhang S; Liang X
    Biomark Med; 2024; 18(10-12):513-521. PubMed ID: 39136445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The investigation of the relationship between Leptin-insulin resistance and pulmonary function in patients with chronic obstructive pulmonary disease with acute exacerbation].
    Pan HY; Lu XZ; Wang DX; Zeng Y; Zhong HB
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):519-21. PubMed ID: 17767817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [C-Reactive protein levels in patients with chronic obstructive pulmonary disease].
    Díaz O; Parada A; Ramos C; Klaassen J; Díaz JC; Andresen M; Lisboa C; Saldías F
    Rev Med Chil; 2012 May; 140(5):569-78. PubMed ID: 23096661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender difference in plasma fatty-acid-binding protein 4 levels in patients with chronic obstructive pulmonary disease.
    Zhang X; Li D; Wang H; Pang C; Wu Y; Wen F
    Biosci Rep; 2016 Jan; 36(1):e00302. PubMed ID: 26823558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of endothelial dysfunction, the interface between hemostatic and system inflammatory responses in the pathogenesis of an infectious inflammation-dependent exacerbation of chronic obstructive pulmonary disease].
    Tseĭmakh IIa; Momot AP; Kostiuchenko GI; Mamaev AN; Filonova IuA; Kornilova TA; Chuchalin AG
    Ter Arkh; 2013; 85(3):17-22. PubMed ID: 23720837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-reactive protein levels in stable COPD patients: a case-control study.
    Silva DR; Gazzana MB; Knorst MM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations.
    Barouchos N; Papazafiropoulou A; Iacovidou N; Vrachnis N; Barouchos N; Armeniakou E; Dionyssopoulou V; Mathioudakis AG; Christopoulou E; Koltsida S; Bassiakou E
    Scand J Clin Lab Invest; 2015 Apr; 75(2):126-32. PubMed ID: 25598350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between serum γ-glutamyltransferase levels and acute exacerbation of chronic obstructive pulmonary disease.
    Ermis H; Celik MR; Gulbas G; Tavli D; Aytemur ZA
    Pol Arch Med Wewn; 2013; 123(3):85-90. PubMed ID: 23344614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carotid atherosclerosis in patients with untreated chronic obstructive pulmonary disease.
    Kim SJ; Yoon DW; Lee EJ; Hur GY; Jung KH; Lee SY; Lee SY; Shin C; Shim JJ; In KH; Kang KH; Yoo SH; Kim JH
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1265-70, i. PubMed ID: 21943856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
    Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
    Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
    Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum cystatin C as a potential biomarker for the evaluation COPD.
    Zhang Y; Zhu Y; Wu Y; Wang G; Xie X; Ke R; Li S; Liu L; Fen W; Li F; Li F; Li M
    Int J Clin Exp Med; 2014; 7(12):5484-90. PubMed ID: 25664059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between bone resorption, oxidative stress and inflammation in severe COPD exacerbation.
    Stanojkovic I; Kotur-Stevuljevic J; Spasic S; Milenkovic B; Vujic T; Stefanovic A; Ivanisevic J
    Clin Biochem; 2013 Nov; 46(16-17):1678-82. PubMed ID: 23954853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Creatinine/Cystatin C Ratio Associated with Cross-Sectional Area of Erector Spinae Muscles and Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease.
    Nishiki K; Nojiri M; Kato R; Shinomiya S; Oikawa T; Ishizaki T; Toga H; Mizuno S
    Int J Chron Obstruct Pulmon Dis; 2021; 16():3513-3524. PubMed ID: 34992359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.